SK pharmteco (SKPT), a global CDMO, part of SK Inc., is investing $35 million for the initial phase of an expansion plan for SK biotek Ireland’s Dublin-based pharmaceutical manufacturing plant. This project will provide an increase in site manufacturing capacity and capabilities for its global customer base. The new building will come on-line during 2024, when the Swords Campus will celebrate 60 years as a small molecule active pharmaceutical ingredients manufacturer. Phase 1 of the projec...